Daniel Cabrera
Overview
Explore the profile of Daniel Cabrera including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
116
Citations
2654
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Aguirre F, Tacchi F, Valero-Breton M, Orozco-Aguilar J, Conejeros-Lillo S, Bonicioli J, et al.
Antioxidants (Basel)
. 2025 Jan;
14(1).
PMID: 39857418
Sarcopenia corresponds to a decrease in muscle mass and strength. CCL5 is a new myokine whose expression, along with the CCR5 receptor, is increased in sarcopenic muscle. Therefore, we evaluated...
2.
Idalsoaga F, Ayares G, Blaney H, Cabrera D, Chahuan J, Monrroy H, et al.
Hepatol Commun
. 2025 Jan;
9(1.
PMID: 39773873
Neurogastroenterology and motility disorders are complex gastrointestinal conditions that are prevalent worldwide, particularly affecting women and younger individuals. These conditions significantly impact the quality of life of people suffering from...
3.
Morey J, Schupbach J, Jones D, Walker L, Lindor R, Loufek B, et al.
Am J Emerg Med
. 2025 Jan;
89:241-246.
PMID: 39755027
Objective: To identify and assess artificial intelligence (AI)-enabled products reviewed by the U.S. Food and Drug Administration (FDA) that are potentially applicable to emergency medicine (EM). Methods: The FDA AI-enabled...
4.
Schmitt C, Mattson A, Cabrera D, Mullan A, Mari Chantada C, Howick A, et al.
J Emerg Med
. 2024 Oct;
67(6):e560-e568.
PMID: 39353791
Background: Diltiazem is an effective rate control agent for atrial fibrillation with rapid ventricular rate (AF RVR). However, its negative inotropic effects may increase the risk for worsening heart failure...
5.
Idalsoaga F, Diaz L, Ayares G, Cabrera D, Chahuan J, Monrroy H, et al.
Aliment Pharmacol Ther
. 2024 Sep;
60(8):1141-1142.
PMID: 39223757
No abstract available.
6.
Idalsoaga F, Diaz L, Ayares G, Cabrera D, Chahuan J, Monrroy H, et al.
Aliment Pharmacol Ther
. 2024 Jul;
60(6):715-726.
PMID: 39082463
Background: Oesophageal disorders and chronic liver disease are common worldwide and significantly impact quality of life. The intricate link between these conditions, including how oesophageal disorders like GERD, Barrett's oesophagus...
7.
Mattson A, Brown C, Sandefur B, Sandefur B, Mara K, Cole K, et al.
Am J Health Syst Pharm
. 2024 Jul;
82(3):e148-e156.
PMID: 39046917
Purpose: Rapid sequence intubation (RSI) is a common emergency department (ED) procedure with an associated complication of postintubation hypotension (PIH). It has not been clearly established whether the selection and...
8.
Saha B, Verma A, Coelho-Prabhu N, Kelm Z, Cabrera D
ACG Case Rep J
. 2024 Jul;
11(7):e01448.
PMID: 39035204
Chilaiditi sign is an incidental radiological finding where the intestine is interposed between the diaphragm and liver. Chilaiditi syndrome (CS), characterized by gastrointestinal symptoms and Chilaiditi sign on imaging, is...
9.
Thakral N, Desalegn H, Diaz L, Cabrera D, Loomba R, Arrese M, et al.
Semin Liver Dis
. 2024 Jul;
44(3):273-286.
PMID: 38991536
The new nomenclature of metabolic dysfunction-associated steatotic liver disease (MASLD) emphasizes a positive diagnosis based on cardiometabolic risk factors. This definition is not only less stigmatizing but also allows for...
10.
Chan T, Thoma B, Finnell J, Gordon B, Farrell S, Pusic M, et al.
AEM Educ Train
. 2024 May;
8(Suppl 1):S5-S16.
PMID: 38774830
Background: Precision medicine, sometimes referred to as personalized medicine, is rapidly changing the possibilities for how people will engage health care in the near future. As technology to support precision...